Brazil Threatens U.S. AIDS Drug Makers With Compulsory Licensing
Raising the specter of compulsory licensing, Brazil's government health ministry has given U.S. drug makers Abbot Laboratories, Merck & Co. and Gilead Sciences Inc. until April 4 to agree on a...To view the full article, register now.
Already a subscriber? Click here to view full article